First randomized clinical trial comparing the efficacy and safety of combined doxycycline 40 mg modified release (DMR) and ivermectin 1% cream (IVM), versus ivermectin 1% cream plus placebo in adults with severe papulopustular rosacea, reveals more than double the number of patients reach ‘clear’ (100% lesion clearance) at 12 weeks

• Regulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylane^® syringe for use with a range of Restylane NASHA^® lidocaine products in multiple indications in the face and in the hands^1-3
• Developed in collaboration with aesthetic practitioners, its

November 5, 2018 (Fort Worth, TX) – Fort Worth-based Galderma is again partnering with the National Breast Cancer Foundation, Inc. (NBCF) to recognize Breast Cancer Awareness Month.

• The company aims to achieve 100% renewable electricity in current factories by 2022
• Science-based strategy will focus on reducing environmental impact, formulating with cleaner ingredients, using smarter packaging and serving communities

The #1 Dermatologist-Recommended Facial Skincare Brand Rallies Behind Skin Cancer Awareness Month with an Integrated Campaign Aimed to Advocate for Sun Protection for All Skin Types Alongside Its Introduction of a 100% Mineral Active Sunscreen Product Line